CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 34 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,259,585 | +21.6% | 6,020,000 | -2.9% | 0.26% | +23.9% |
| Q1 2023 | $7,615,069 | +6.9% | 6,198,000 | -1.4% | 0.21% | +14.8% |
| Q4 2022 | $7,123,996 | -1.8% | 6,287,000 | -5.0% | 0.18% | -0.5% |
| Q3 2022 | $7,255,000 | -11.5% | 6,619,000 | -2.4% | 0.18% | -8.0% |
| Q2 2022 | $8,195,000 | -87.5% | 6,783,000 | -82.2% | 0.20% | -65.4% |
| Q1 2022 | $65,472,000 | +3.7% | 38,008,000 | +0.3% | 0.58% | +9.5% |
| Q4 2021 | $63,163,000 | +6.3% | 37,899,000 | -1.1% | 0.52% | -6.2% |
| Q3 2021 | $59,400,000 | -4.0% | 38,329,000 | +0.1% | 0.56% | -3.6% |
| Q2 2021 | $61,845,000 | +11.0% | 38,286,000 | +7.7% | 0.58% | +43.1% |
| Q1 2021 | $55,708,000 | +22.7% | 35,548,000 | +9.8% | 0.41% | +29.7% |
| Q4 2020 | $45,397,000 | +42.2% | 32,384,000 | +14.1% | 0.31% | +44.2% |
| Q3 2020 | $31,930,000 | +8.4% | 28,394,000 | +1.4% | 0.22% | -7.7% |
| Q2 2020 | $29,448,000 | +13.2% | 28,004,000 | +0.2% | 0.24% | -2.5% |
| Q1 2020 | $26,009,000 | – | 27,947,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 44,065,000 | $71,296,000 | 7.64% |
| Mohican Financial Management, LLC | 3,000,000 | $4,878,000 | 1.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,398,000 | $15,357,000 | 1.40% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $14,433,000 | 0.74% |
| SSI INVESTMENT MANAGEMENT LLC | 6,454,000 | $10,396,000 | 0.67% |
| MACKAY SHIELDS LLC | 38,286,000 | $61,845,000 | 0.58% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,208,000 | $8,417,000 | 0.19% |
| Calamos Advisors LLC | 23,085,000 | $37,345,000 | 0.17% |
| Polar Asset Management Partners Inc. | 10,000,000 | $16,168,000 | 0.17% |
| Calamos Wealth Management LLC | 1,026,000 | $1,660,000 | 0.13% |